Today, the San Francisco-based health and wellness platform Hims & Hers Health, Inc. announced its global expansion plans as it entered into an agreement to acquire ZAVA, a leading digital health platform in Europe.
The acquisition is expected to close in the second half of 2025 and will consist of 100% cash. The cost of the deal remains undisclosed.
Andrew Dudum, founder and CEO of Hims & Hers told investors, “The demand for simpler, more personalized healthcare is universal. By leveraging ZAVA’s established European presence, cutting-edge technology, and deep customer understanding, we’re poised to fundamentally transform access to care for millions across Europe.”
David Meinertz, co-founder and CEO of ZAVA stated, “Together we’ll pair ZAVA’s trusted clinical services, established footprint, and deep understanding of the European healthcare landscape with the Hims & Hers experience to make affordable access to high-quality, personalized care the rule, not the exception. I’m thrilled to be working with Andrew and his team. It’s still day one for digital healthcare, and I can’t wait to see what we’ll achieve for patients in the years ahead.”
Speaking to the media after the announcement, Dudum stated that despite macroeconomic uncertainty, moving forward is the right decision for his company. “The pricing on pharmaceuticals is so much more consumer advantageous in broader Europe relative to the U.S. The ability to bring accessible, personalized treatments to customers overseas may be equal or easier than what we see domestically just given the pricing and complexities of insurance and [pharmacy benefit managers] and the pricing power that exists here.”
By CEO NA Editorial Staff
